1Park CS, Ihm SH, Yoo KD, et al. Relation between C reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for eardiovas cular disease among healthy adults in the USA. Am J Cardiol,2010,105(9):1284-1288.
2Manginas A, Bei E, Chaidaroglou A, et al. Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive Pro- rein are elevated in patients with acute coronary syndromes : Cor- relations with serum troponin I. Clin Cardiol, 2005,28(4):182- 186.
3Kruk M, Przyluski J, KalificzukL, et al. Association of non- specific inflammatory activation with early mortality in patiems with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J, 2008,72(2):205-211.
4Fournier JA, Delgado-Pecelln C, Cayuela A, et aI. The high- sensitivity C-reactive protein level one month after bare-metal coronary stenting may predict late adverse events. Rev Esp Car- diol, 2008,61(3) :313-316.
5Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal ap- plication of sirolimus-eluting versus bare metal stents for critical limb isehemia: Analysis of long term angiographic and clinical outcome. J VasclntervRadiol, 2009,20(9):1141-1150.
6Zeller T, Frank U, Burgelin K, et al. Initial clinical experence with percutaneous atherectomy in the infragenicular ateries. J Endovasc Ther, 2003,10(5):987-993.
